PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12138269-0	2002	Effect of ticlopidine hydrochloride on erythropoietin-induced rise in blood pressure in patients on maintenance hemodialysis.	Ticlopidine	10-35	erythropoietin	Homo sapiens	39-53	
12138269-1	2002	BACKGROUND/AIMS: A recent observation that antiplatelet-aggregation drugs, including ticlopidine hydrochloride, may prevent erythropoietin (EPO)-induced rise in blood pressure in hemodialysis (HD) patients remains a subject of particular interest.	Ticlopidine	85-110	erythropoietin	Homo sapiens	124-138	
12138269-1	2002	BACKGROUND/AIMS: A recent observation that antiplatelet-aggregation drugs, including ticlopidine hydrochloride, may prevent erythropoietin (EPO)-induced rise in blood pressure in hemodialysis (HD) patients remains a subject of particular interest.	Ticlopidine	85-110	erythropoietin	Homo sapiens	140-143	
12138269-2	2002	The aim of the present study was to determine the effect of ticlopidine hydrochloride on EPO-induced rise in blood pressure of HD patients with special reference to blood levels of vasoactive substances.	Ticlopidine	60-85	erythropoietin	Homo sapiens	89-92	
12138269-10	2002	CONCLUSION: The findings suggest that the preventive effect of ticlopidine hydrochloride on EPO-induced rise in blood pressure may partly be related to the enhancement of NO production in patients on maintenance HD.	Ticlopidine	63-88	erythropoietin	Homo sapiens	92-95